JP Morgan Chase
TCBP

JP Morgan Chase’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

JP Morgan Chase’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105
Closed -$1.08K – 7895
2024
Q4 		$1.08K Buy
+105
New +$3.25K ﹤0.01% 6718
2024
Q1 		– Sell
-1
Closed -$282 – 8106
2023
Q4 		$282 Buy
+1
New +$1.13K ﹤0.01% 7019

Other funds holding TCBP

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

JP Morgan Chase's TCBP Position: Q1 2025 in Review

JP Morgan Chase sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q1 2025, closing a stake of 105 shares — an estimated $1.08K sold.

JP Morgan Chase first reported a position in TCBP in Q4 2023 and held it in 2 quarters. The position peaked at $1.08K in Q4 2024. 2 funds tracked by Wall St. Rank hold TCBP as of Q1 2025.

  • JP Morgan Chase reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 105 TC BioPharm (Holdings) plc American Depositary Shares shares in Q1 2025, an estimated $1.08K.
  • JP Morgan Chase first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q4 2023 and held it in 2 quarters.
  • JP Morgan Chase's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $1.08K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.